Phase II clinical trial of nab‐paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer.

Saved in:
Bibliographic Details
Title: Phase II clinical trial of nab‐paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer.
Authors: Jameson, Gayle S.1,2 (AUTHOR) gjameson@honorhealth.com, Hosein, Peter J.3 (AUTHOR), Pierce, Erin4 (AUTHOR), Kamgar, Mandana5 (AUTHOR), Gordon, Michael S.1 (AUTHOR), Snyder, Courtney1 (AUTHOR), Roe, Denise J.6 (AUTHOR), Wertheim, Betsy C.6 (AUTHOR), Davey, Marina1 (AUTHOR), Barrett, Michael T.7 (AUTHOR), Von Hoff, Daniel D.1,2 (AUTHOR), Borazanci, Erkut1,2 (AUTHOR)
Source: Cancer Medicine. Jun2024, Vol. 13 Issue 12, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.7412